search
Back to results

Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department

Primary Purpose

Low Back Pain

Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Paracetamol
Ibuprofen
Sponsored by
Pamukkale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain focused on measuring Low Back Pain, Ibuprofen, Paracetamol, Emergency Medicine

Eligibility Criteria

21 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who presented with complaints of low back pain to the emergency services ,
  • Patients whose complaints have started in the last week,
  • Younger than 21 years old,
  • older than 80 years old,

Exclusion Criteria:

  • Pretreatment linear 100-mm visual analog scale (VAS) pain score less than 40 mm,
  • Patients who have drop foot, paralysis and other neurological symptoms in physical examination.
  • Patients with blood pressure less than 90mmHg in the arrival of emergency services.
  • Patients with malignancy, cauda equina syndrome, ankylosing spondylitis, rheumatoid arthritis or inflammatory arthritis contain any of the disease in his/her CV.
  • Patients with any history of chronic pain syndrome.
  • Patients who receive pain killers, antidepressants, anticonvulsants, muscle relaxants, steroids within 6 hours before the ED visit,
  • Patients have a history of active peptic ulcer disease,
  • Patients who have signs of peritoneal irritation,
  • Patients had a fever (>37.9)
  • Allergy or previous adverse reaction to the studied drugs(Ibuprofen, Paracetamol), received agents to inhibit the secretion of acid (PPIs or histamine-2 receptor antagonists), antispasmodics, or nonsteroidal anti-inflammatory drugs
  • were pregnant or breast-feeding,
  • inability to comprehend the VAS evaluation,
  • or refused to participate in the study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Experimental

    Arm Label

    paracetamol group

    Ibuprofen group

    Arm Description

    First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume)

    Second Group: 800 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes

    Outcomes

    Primary Outcome Measures

    Reduction of Low Back Pain on the Visual Analog Scale

    Secondary Outcome Measures

    Adverse events
    30th minutes after the study drug administered

    Full Information

    First Posted
    July 1, 2016
    Last Updated
    July 18, 2016
    Sponsor
    Pamukkale University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02836509
    Brief Title
    Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department
    Official Title
    Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 2016 (undefined)
    Primary Completion Date
    December 2016 (Anticipated)
    Study Completion Date
    March 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Pamukkale University

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments. The objective of the study was to assess whether intravenous Paracetamol has superior Low Back Pain reduction will compare with Ibuprofen in emergency department (ED) adults. Half of the participants will receive Paracetamol and the other half will receive Ibuprofen.
    Detailed Description
    Paracetamol and Ibuprofen each relieve pain with different mechanisms. Paracetamol is termed a simple analgesic and an antipyretic. Despite enduring assertions that it acts by inhibition of cyclooxygenase (COX)-mediated production of prostaglandins, unlike non-steroidal anti-inflammatory drugs (NSAIDs). Ibuprofen is the most commonly used and most frequently prescribed NSAID. It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Although its anti inflammatory properties may be weaker than those of some other NSAIDs, it has a prominent analgesic and antipyretic role. In the investigators trial; The investigators aimed to compare intravenous Paracetamol and Ibuprofen in patient with Low Back Pain All patients eligible for the study were randomized to one of two groups: First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. 100 ml of saline is removed before the addition of the 100 ml paracetamol (Perfalgan, Bristol Myers, Italy) to be the same volume. Second Group: 800mg Ibuprofen (Intrafen Flk, Gen drug, Turkey) in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. Drug packs were prepared according to the computer-generated random number sequence to assign treatment allocations The allocation list was kept by the emergency nurse. Patients received the paracetamol or Ibuprofen medication schemes according to their random allocations. After enrollment and recording of baseline information, the next numbered study drug pack was obtained, and administered as a infusion over 5 minutes. Randomization was achieved by using computer software to generate random numbers. One researcher blinded to patient allocation observed the whole procedure and recorded the Low Back Pain scores. Patients in both groups received two types of medication in a similar manner (for example, 150 ml normal saline given as a slow intravenous infusion over 5 minutes), thus ensuring double blinding. Low Back Pain scores were recorded at 0, 15, and 30 min on a VAS of 1 to 10 Rescue medication is given within 30 minutes after study drug administration if the patients say yes that question "Do you need any additional analgesic requirement". All other medications required during the study also were recorded.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Low Back Pain
    Keywords
    Low Back Pain, Ibuprofen, Paracetamol, Emergency Medicine

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Factorial Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    200 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    paracetamol group
    Arm Type
    Experimental
    Arm Description
    First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume)
    Arm Title
    Ibuprofen group
    Arm Type
    Experimental
    Arm Description
    Second Group: 800 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes
    Intervention Type
    Drug
    Intervention Name(s)
    Paracetamol
    Other Intervention Name(s)
    PERFALGAN, PARTEMOL, PAROL
    Intervention Description
    1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes.
    Intervention Type
    Drug
    Intervention Name(s)
    Ibuprofen
    Other Intervention Name(s)
    intrafen, Caldolon
    Intervention Description
    800 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes
    Primary Outcome Measure Information:
    Title
    Reduction of Low Back Pain on the Visual Analog Scale
    Time Frame
    Low Back Pain scores will be recorded at 0, 15, and 30 min on a VAS of 1 to 10
    Secondary Outcome Measure Information:
    Title
    Adverse events
    Description
    30th minutes after the study drug administered
    Time Frame
    30th minutes after the study drug administered

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    21 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients who presented with complaints of low back pain to the emergency services , Patients whose complaints have started in the last week, Younger than 21 years old, older than 80 years old, Exclusion Criteria: Pretreatment linear 100-mm visual analog scale (VAS) pain score less than 40 mm, Patients who have drop foot, paralysis and other neurological symptoms in physical examination. Patients with blood pressure less than 90mmHg in the arrival of emergency services. Patients with malignancy, cauda equina syndrome, ankylosing spondylitis, rheumatoid arthritis or inflammatory arthritis contain any of the disease in his/her CV. Patients with any history of chronic pain syndrome. Patients who receive pain killers, antidepressants, anticonvulsants, muscle relaxants, steroids within 6 hours before the ED visit, Patients have a history of active peptic ulcer disease, Patients who have signs of peritoneal irritation, Patients had a fever (>37.9) Allergy or previous adverse reaction to the studied drugs(Ibuprofen, Paracetamol), received agents to inhibit the secretion of acid (PPIs or histamine-2 receptor antagonists), antispasmodics, or nonsteroidal anti-inflammatory drugs were pregnant or breast-feeding, inability to comprehend the VAS evaluation, or refused to participate in the study
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Mustafa SERINKEN, professor
    Phone
    505 2991497
    Email
    aserinken@hotmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    hayri eliçabuk, medical Doctor
    Phone
    5385079500
    Email
    hayrielicabuk@hotmail.com

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Low Back Pain Presented to the Emergency Department

    We'll reach out to this number within 24 hrs